Topics in Current Chemistry (2020) 378:40
1 3
251. Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219(2):316–333. https ://doi.
org/10.1148/radio logy.219.2.r01ma 19316
252. Torrey HC (1956) Bloch equations with diffusion terms. Phys Rev 104(3):563–565. https ://doi.
org/10.1103/PhysR ev.104.563
253. Enriquez-Navas PM, Garcia-Martin ML (2012) Chapter 9—application of inorganic nanoparticles
for diagnosis based on MRI. In: de la Fuente JM, Grazu V (eds) Frontiers of nanoscience, vol 4.
Elsevier, Oxford, pp 233–245. https ://doi.org/10.1016/B978-0-12-41576 9-9.00009 -1
254. Geraldes CF, Laurent S (2009) Classification and basic properties of contrast agents for magnetic
resonance imaging. Contrast Media Mol Imaging 4(1):1–23. https ://doi.org/10.1002/cmmi.265
255. Yan G-P, Robinson L, Hogg P (2007) Magnetic resonance imaging contrast agents: overview and
perspectives. Radiography 13:e5–e19. https ://doi.org/10.1016/j.radi.2006.07.005
256. Bridot J-L, Faure A-C, Laurent S, Rivière C, Billotey C, Hiba B, Janier M, Josserand V, Coll J-L,
Vander Elst L, Muller R, Roux S, Perriat P, Tillement O (2007) Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J Am Chem Soc 129(16):5076–5084. https
://doi.org/10.1021/ja068 356j
257. Ersoy H, Rybicki FJ (2007) Biochemical safety profiles of gadolinium-based extracellular contrast
agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 26(5):1190–1197. https ://doi.
org/10.1002/jmri.21135
258. Dias MHM, Lauterbur PC (1986) Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen. Magn Reson Med 3(2):328–330. https ://doi.org/10.1002/
mrm.19100 30218
259. Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GE (2009) Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat Protoc
4(11):1670–1680. https ://doi.org/10.1038/nprot .2009.171
260. Jin K, Teng L, Shen Y, He K, Xu Z, Li G (2010) Patient-derived human tumour tissue xenografts
in immunodeficient mice: a systematic review. Clin Transl Oncol 12(7):473–480. https ://doi.
org/10.1007/s1209 4-010-0540-6
261. Carlos C, David P (2015) Polysaccharide colloids as smart vehicles in cancer therapy. Curr Pharm
Des 21(33):4822–4836. https ://doi.org/10.2174/13816 12821 66615 08201 00812
262. Efremova MV, Naumenko VA, Spasova M, Garanina AS, Abakumov MA, Blokhina AD, Melnikov PA, Prelovskaya AO, Heidelmann M, Li Z-A, Ma Z, Shchetinin IV, Golovin YI, Kireev II,
Savchenko AG, Chekhonin VP, Klyachko NL, Farle M, Majouga AG, Wiedwald U (2018) Magnetite–gold nanohybrids as ideal all-in-one platforms for theranostics. Sci Rep 8(1):11295. https ://doi.
org/10.1038/s4159 8-018-29618 -w
263. Li Y, Song K, Cao Y, Peng C, Yang G (2018) Keratin-templated synthesis of metallic oxide nanoparticles as MRI contrast agents and drug carriers. ACS Appl Mater Interfaces 10(31):26039–
26045. https ://doi.org/10.1021/acsam i.8b085 55
264. Hsu JC, Naha PC, Lau KC, Chhour P, Hastings R, Moon BF, Stein JM, Witschey WRT, McDonald
ES, Maidment ADA, Cormode DP (2018) An all-in-one nanoparticle (AION) contrast agent for
breast cancer screening with DEM-CT-MRI-NIRF imaging. Nanoscale 10(36):17236–17248. https
://doi.org/10.1039/C8NR0 3741H
265. Ren S, Yang J, Ma L, Li X, Wu W, Liu C, He J, Miao L (2018) Ternary-responsive drug delivery with activatable dual mode contrast-enhanced in vivo imaging. ACS Appl Mater Interfaces
10(38):31947–31958. https ://doi.org/10.1021/acsam i.8b105 64
266. Shirvalilou S, Khoei S, Khoee S, Raoufi NJ, Karimi MR, Shakeri-Zadeh A (2018) Development
of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations. Chem Biol Interact 295:97–108. https ://doi.org/10.1016/j.
cbi.2018.08.027
267. Sun J, Xu W, Li L, Fan B, Peng X, Qu B, Wang L, Li T, Li S, Zhang R (2018) Ultrasmall endogenous biopolymer nanoparticles for magnetic resonance/photoacoustic dual-modal imaging-guided
photothermal therapy. Nanoscale 10(22):10584–10595. https ://doi.org/10.1039/C8NR0 1215F
268. Thirunavukkarasu GK, Cherukula K, Lee H, Jeong YY, Park I-K, Lee JY (2018) Magnetic fieldinducible drug-eluting nanoparticles for image-guided thermo-chemotherapy. Biomaterials
180:240–252. https ://doi.org/10.1016/j.bioma teria ls.2018.07.028
269. Zhang J, Mu Y-L, Ma Z-Y, Han K, Han H-Y (2018) Tumor-triggered transformation of chimeric
peptide for dual-stage-amplified magnetic resonance imaging and precise photodynamic therapy.
Biomaterials 182:269–278. https ://doi.org/10.1016/j.bioma teria ls.2018.08.026
88
Reprinted from the journal
1 3
251. Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219(2):316–333. https ://doi.
org/10.1148/radio logy.219.2.r01ma 19316
252. Torrey HC (1956) Bloch equations with diffusion terms. Phys Rev 104(3):563–565. https ://doi.
org/10.1103/PhysR ev.104.563
253. Enriquez-Navas PM, Garcia-Martin ML (2012) Chapter 9—application of inorganic nanoparticles
for diagnosis based on MRI. In: de la Fuente JM, Grazu V (eds) Frontiers of nanoscience, vol 4.
Elsevier, Oxford, pp 233–245. https ://doi.org/10.1016/B978-0-12-41576 9-9.00009 -1
254. Geraldes CF, Laurent S (2009) Classification and basic properties of contrast agents for magnetic
resonance imaging. Contrast Media Mol Imaging 4(1):1–23. https ://doi.org/10.1002/cmmi.265
255. Yan G-P, Robinson L, Hogg P (2007) Magnetic resonance imaging contrast agents: overview and
perspectives. Radiography 13:e5–e19. https ://doi.org/10.1016/j.radi.2006.07.005
256. Bridot J-L, Faure A-C, Laurent S, Rivière C, Billotey C, Hiba B, Janier M, Josserand V, Coll J-L,
Vander Elst L, Muller R, Roux S, Perriat P, Tillement O (2007) Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J Am Chem Soc 129(16):5076–5084. https
://doi.org/10.1021/ja068 356j
257. Ersoy H, Rybicki FJ (2007) Biochemical safety profiles of gadolinium-based extracellular contrast
agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 26(5):1190–1197. https ://doi.
org/10.1002/jmri.21135
258. Dias MHM, Lauterbur PC (1986) Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen. Magn Reson Med 3(2):328–330. https ://doi.org/10.1002/
mrm.19100 30218
259. Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GE (2009) Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat Protoc
4(11):1670–1680. https ://doi.org/10.1038/nprot .2009.171
260. Jin K, Teng L, Shen Y, He K, Xu Z, Li G (2010) Patient-derived human tumour tissue xenografts
in immunodeficient mice: a systematic review. Clin Transl Oncol 12(7):473–480. https ://doi.
org/10.1007/s1209 4-010-0540-6
261. Carlos C, David P (2015) Polysaccharide colloids as smart vehicles in cancer therapy. Curr Pharm
Des 21(33):4822–4836. https ://doi.org/10.2174/13816 12821 66615 08201 00812
262. Efremova MV, Naumenko VA, Spasova M, Garanina AS, Abakumov MA, Blokhina AD, Melnikov PA, Prelovskaya AO, Heidelmann M, Li Z-A, Ma Z, Shchetinin IV, Golovin YI, Kireev II,
Savchenko AG, Chekhonin VP, Klyachko NL, Farle M, Majouga AG, Wiedwald U (2018) Magnetite–gold nanohybrids as ideal all-in-one platforms for theranostics. Sci Rep 8(1):11295. https ://doi.
org/10.1038/s4159 8-018-29618 -w
263. Li Y, Song K, Cao Y, Peng C, Yang G (2018) Keratin-templated synthesis of metallic oxide nanoparticles as MRI contrast agents and drug carriers. ACS Appl Mater Interfaces 10(31):26039–
26045. https ://doi.org/10.1021/acsam i.8b085 55
264. Hsu JC, Naha PC, Lau KC, Chhour P, Hastings R, Moon BF, Stein JM, Witschey WRT, McDonald
ES, Maidment ADA, Cormode DP (2018) An all-in-one nanoparticle (AION) contrast agent for
breast cancer screening with DEM-CT-MRI-NIRF imaging. Nanoscale 10(36):17236–17248. https
://doi.org/10.1039/C8NR0 3741H
265. Ren S, Yang J, Ma L, Li X, Wu W, Liu C, He J, Miao L (2018) Ternary-responsive drug delivery with activatable dual mode contrast-enhanced in vivo imaging. ACS Appl Mater Interfaces
10(38):31947–31958. https ://doi.org/10.1021/acsam i.8b105 64
266. Shirvalilou S, Khoei S, Khoee S, Raoufi NJ, Karimi MR, Shakeri-Zadeh A (2018) Development
of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations. Chem Biol Interact 295:97–108. https ://doi.org/10.1016/j.
cbi.2018.08.027
267. Sun J, Xu W, Li L, Fan B, Peng X, Qu B, Wang L, Li T, Li S, Zhang R (2018) Ultrasmall endogenous biopolymer nanoparticles for magnetic resonance/photoacoustic dual-modal imaging-guided
photothermal therapy. Nanoscale 10(22):10584–10595. https ://doi.org/10.1039/C8NR0 1215F
268. Thirunavukkarasu GK, Cherukula K, Lee H, Jeong YY, Park I-K, Lee JY (2018) Magnetic fieldinducible drug-eluting nanoparticles for image-guided thermo-chemotherapy. Biomaterials
180:240–252. https ://doi.org/10.1016/j.bioma teria ls.2018.07.028
269. Zhang J, Mu Y-L, Ma Z-Y, Han K, Han H-Y (2018) Tumor-triggered transformation of chimeric
peptide for dual-stage-amplified magnetic resonance imaging and precise photodynamic therapy.
Biomaterials 182:269–278. https ://doi.org/10.1016/j.bioma teria ls.2018.08.026
88
Reprinted from the journal